shutterstock_1189876495_jarretera
26 July 2021PatentsMuireann Bolger

USPTO’s Arthrex guidance offers window into agency’s thinking

Amid mounting speculation over the uncertainty caused by the US Supreme Court decision’s landmark decision in US v Arthrex, the  United States Patent and Trademark Office (USPTO) has posted several updates issuing guidance. But lawyers tell WIPR that some key questions remain.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Patents
3 November 2020   In October, the US Supreme Court agreed to hear Arthrex v Smith & Nephew. Jason Romrell, Derek McCorquindale, and Brandon Andersen of Finnegan, Henderson, Farabow, Garrett & Dunner, outline what this means.
Patents
23 July 2021   Despite the latest challenge to its legitimacy, the US Patent Trial and Appeal Board has survived—and survive it must, say David McCombs, Joe Matal, and Eugene Goryunov of Haynes and Boone.